Correlation Between Jupiter Neurosciences, and Eupraxia Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Jupiter Neurosciences, and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jupiter Neurosciences, and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jupiter Neurosciences, Common and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on Jupiter Neurosciences, and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jupiter Neurosciences, with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jupiter Neurosciences, and Eupraxia Pharmaceuticals.

Diversification Opportunities for Jupiter Neurosciences, and Eupraxia Pharmaceuticals

-0.11

Correlation Coefficient

Jupiter Neurosciences,  Eupraxia Pharmaceuticals

Good diversification

The 3 months correlation between Jupiter and Eupraxia is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Jupiter Neurosciences, Common and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Jupiter Neurosciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jupiter Neurosciences, Common are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Jupiter Neurosciences, i.e., Jupiter Neurosciences, and Eupraxia Pharmaceuticals go up and down completely randomly.

Pair Corralation between Jupiter Neurosciences, and Eupraxia Pharmaceuticals

Given the investment horizon of 90 days Jupiter Neurosciences, Common is expected to generate 2.85 times more return on investment than Eupraxia Pharmaceuticals. However, Jupiter Neurosciences, is 2.85 times more volatile than Eupraxia Pharmaceuticals Common. It trades about 0.39 of its potential returns per unit of risk. Eupraxia Pharmaceuticals Common is currently generating about 0.08 per unit of risk. If you would invest  549.00  in Jupiter Neurosciences, Common on September 25, 2024 and sell it today you would earn a total of  639.00  from holding Jupiter Neurosciences, Common or generate 116.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	25.4%
Values	Daily Returns

Jupiter Neurosciences, Common  vs.  Eupraxia Pharmaceuticals Commo

Jupiter Neurosciences,

Risk-Adjusted Performance

30 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Jupiter Neurosciences, Common are ranked lower than 30 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Jupiter Neurosciences, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Eupraxia Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Jupiter Neurosciences, and Eupraxia Pharmaceuticals

The main advantage of trading using opposite Jupiter Neurosciences, and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jupiter Neurosciences, position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.

The idea behind Jupiter Neurosciences, Common and Eupraxia Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.